Results 241 to 250 of about 10,448 (268)

Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial

Lancet Respiratory Medicine,the, 2021
Jürgen Behr, Steven D Nathan, Wim A Wuyts   +2 more
exaly  

Sildenafil citrate

Dimensions of Critical Care Nursing, 2000
openaire   +2 more sources

Sildenafil Citrate

2001
Adnan A. Badwan, Lina Nabulsi, Mahmoud M. Al-Omari, Nidal Daraghmeh, Mahmoud Ashour   +4 more
openaire   +1 more source

Sildenafil Citrate, the Classic PDE5 Inhibitor

2005
In 1988, a new class of drugs was heralded by the release of sildenafil citrate, an orally administered, potent, and selective phosphodiesterase type 5 (PDE5) inhibitor.
openaire   +2 more sources

Correspondence

Retina, 2011
Won June Lee, Mincheol Seong
openaire   +3 more sources

INTRACAVERNOSAL INJECTION OF SILDENAFIL CITRATE: MISAPPLICATION OF THE DRUG

Journal of Urology, 2001
Hana Yoon, Ji Suk Lim, Woo Sik Chung, Young Yo Park, Dong Suk Kim   +4 more
openaire   +3 more sources

Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond

Nature Reviews Drug Discovery, 2006
Ardeschir Ghofrani
exaly  

Sildenafil Citrate

2016
openaire   +1 more source

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

Lancet, The, 2002
Ardeschir Ghofrani, Ralph T Schermuly, Horst Olschewski   +2 more
exaly  

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension

Circulation, 2012
Dunbar Ivy
exaly